UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
UBcare wins patent for tech to monitor suspected infectious diseases
by Shim Hyun-tai
2020-09-04 18:04
Chong Kun Dang to conduct P2 trials of Covid-19 therapy in Russia
by Shim Hyun-tai
2020-09-03 12:36
Recovered Covid-19 patients suffer from aftereffects – for long
by Shim Hyun-tai
2020-09-02 20:12
Nation struggles to secure beds, workforce for severe Covid-19 patients
by Shim Hyun-tai
2020-09-02 16:15
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
by Shim Hyun-tai
2020-09-02 14:08
라인
Korea approved 22 clinical studies for Covid-19 vaccines, treatments
by Shim Hyun-tai
2020-09-01 18:02
MedPacto’s oncology pipeline for blood cancer wins EU patent
by Shim Hyun-tai
2020-09-01 17:14
MSD’s antiviral Prevymis gains insurance coverage
by Shim Hyun-tai
2020-09-01 15:05
T&R Biofab gains sales rights of pluripotent stem cell-derived cardiomyocyte
by Shim Hyun-tai
2020-09-01 14:13
MSD Korea’s Keytruda wins 2 new indications for treating cancer
by Shim Hyun-tai
2020-08-31 16:44
라인
China gives nod to Huonland’s eye drop for allergic inflammation
by Shim Hyun-tai
2020-08-31 15:28
SNUH to introduce Toshiba’s heavy ion radiotherapy device
by Shim Hyun-tai
2020-08-31 14:02
‘AI MRI model can diagnose autism’s severity, prognosis’
by Shim Hyun-tai
2020-08-28 18:04
Regulator names 2 more innovative medical devices
by Shim Hyun-tai
2020-08-28 18:03
Takeda’s Alunbrig available as primary therapy for lung cancer
by Shim Hyun-tai
2020-08-28 15:52
라인
Capital area tops Daegu as Covid-19 epicenter
by Shim Hyun-tai
2020-08-28 14:54
‘Thyroid surgery using oral endoscopy reduces swallowing difficulties’
by Shim Hyun-tai
2020-08-27 18:06
SNUH opens new Covid-19 treatment center in 2 days
by Shim Hyun-tai
2020-08-27 18:06
Genexine's cytokine drug effective on severe Covid-19 patients
by Shim Hyun-tai
2020-08-27 18:05
New virus cases reach six-month high; tightest restrictions imminent
by Shim Hyun-tai
2020-08-27 13:24
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top